Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 5505-5505 ◽  
Author(s):  
K. J. Harrington ◽  
A. Berrier ◽  
M. Robinson ◽  
E. Remenar ◽  
M. Housset ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Kinase Inhibitor ◽  
Phase Ii Study ◽  
Locally Advanced

scholarly journals Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

Head & Neck ◽  
2014 ◽  
Vol 37 (11) ◽  
pp. 1665-1671 ◽  
Author(s):  
Min Yao ◽  
Nicholas Galanopoulos ◽  
Pierre Lavertu ◽  
Pingfu Fu ◽  
Michael Gibson ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Advanced Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document